These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 230767)

  • 21. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
    Scott FW
    Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.
    Hofmann-Lehmann R; Tandon R; Boretti FS; Meli ML; Willi B; Cattori V; Gomes-Keller MA; Ossent P; Golder MC; Flynn JN; Lutz H
    Vaccine; 2006 Feb; 24(8):1087-94. PubMed ID: 16198454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression.
    Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M
    Clin Vaccine Immunol; 2015 Jul; 22(7):798-805. PubMed ID: 25972402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of feline leukemia virus immunity.
    Charreyre C; Pedersen NC
    J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum.
    Rice JB; Olsen RG
    J Natl Cancer Inst; 1981 Apr; 66(4):737-43. PubMed ID: 6262553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of anesthesia and surgery on serologic responses to vaccination in kittens.
    Reese MJ; Patterson EV; Tucker SJ; Dubovi EJ; Davis RD; Crawford PC; Levy JK
    J Am Vet Med Assoc; 2008 Jul; 233(1):116-21. PubMed ID: 18593319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.
    Pedersen NC; Johnson L; Birch D; Theilen GH
    Vet Immunol Immunopathol; 1986 Feb; 11(2):123-48. PubMed ID: 3008409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination against feline leukaemia virus using a cell membrane antigen system.
    Jarrett W; Jarrett O; Mackey L; Laird H; Hood C; Hay D
    Int J Cancer; 1975 Jul; 16(1):134-41. PubMed ID: 170211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge.
    Stuke K; King V; Southwick K; Stoeva MI; Thomas A; Winkler MT
    Vaccine; 2014 May; 32(22):2599-603. PubMed ID: 24662705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Year two of follow-up evaluation of a randomized, blind field trial of a commercial feline leukemia virus vaccine.
    Scarlett JM; Pollock RV
    J Am Vet Med Assoc; 1991 Nov; 199(10):1431-2. PubMed ID: 1666098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine.
    Jirjis FF; Davis T; Lane J; Carritt K; Sweeney D; Williams J; Wasmoen T
    Vet Ther; 2010; 11(2):E1-6. PubMed ID: 20957616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus.
    Pedersen NC; Black JW
    Am J Vet Res; 1983 Feb; 44(2):229-34. PubMed ID: 6299143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a subunit feline leukemia virus vaccine in exotic cats.
    Citino SB
    J Am Vet Med Assoc; 1988 Apr; 192(7):957-9. PubMed ID: 2835347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine.
    Harbour DA; Gunn-Moore DA; Gruffydd-Jones TJ; Caney SM; Bradshaw J; Jarrett O; Wiseman A
    Vaccine; 2002 Jul; 20(23-24):2866-72. PubMed ID: 12126896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H; Pedersen NC; Theilen GH
    Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of feral cats to vaccination at the time of neutering.
    Fischer SM; Quest CM; Dubovi EJ; Davis RD; Tucker SJ; Friary JA; Crawford PC; Ricke TA; Levy JK
    J Am Vet Med Assoc; 2007 Jan; 230(1):52-8. PubMed ID: 17199493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized blind trial of a commercial FeLV vaccine.
    Pollock RV; Scarlett JM
    J Am Vet Med Assoc; 1990 Feb; 196(4):611-6. PubMed ID: 2154424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.